Cargando…
Tocilizumab in severe COVID-19 – A randomized, double-blind, placebo-controlled trial
BACKGROUND: The therapeutic effectiveness of interleukin-6 receptor inhibitor in critically ill hospitalized patients with coronavirus disease 2019 (COVID-19) is uncertain. METHODS: To evaluate the efficacy and safety of the outcome as recovery or death of tocilizumab for severe acute respiratory sy...
Autores principales: | Malik, Muhammad Irfan, Zafar, Sardar Al Fareed, Qayyum, Fabiha, Malik, Muna, Asghar, Muhammad Sohaib, Tahir, Muhammad Junaid, Arshad, Ammarah, Khalil, Fatima, Naz, Hafiza Shafia, Aslam, Mudassar, Saleem, Jodat, Aziz, Abdul, Azhar, Mustafa Usman, Naqash, Muhammad, Yousaf, Zohaib |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161690/ https://www.ncbi.nlm.nih.gov/pubmed/38013720 http://dx.doi.org/10.1016/j.imj.2022.05.001 |
Ejemplares similares
-
The utility of remdesivir in SARS-CoV-2: A single tertiary care center experience from a developing country
por: Malik, Muhammad Irfan, et al.
Publicado: (2022) -
Knowledge, attitude, and practice of artificial intelligence among doctors and medical students in Pakistan: A cross-sectional online survey
por: Ahmed, Zaboor, et al.
Publicado: (2022) -
Awareness, anxiety, and depression in healthcare professionals, medical students, and general population of Pakistan during COVID-19 Pandemic: A cross sectional online survey
por: Muhammad Alfareed Zafar, Sardar, et al.
Publicado: (2020) -
COVID-19 Omicron variant - Time for airborne precautions
por: Yousaf, Zohaib, et al.
Publicado: (2022) -
The utility of point of care ultrasonography (POCUS)
por: Hashim, Ahmed, et al.
Publicado: (2021)